Factores de riesgo de descarga catecolaminérgica y/o inestabilidad hemodinámica en la cirugía del feocromocitoma

Autores/as

DOI:

https://doi.org/10.23857/dc.v9i4.3699

Palabras clave:

Feocromocitoma, neoplasias neuroendocrinas, catecolaminas, hipersecreción, morbimortalidad

Resumen

Las feocromocitomas son neoplasias neuroendocrinas poco frecuentes que se caracterizan por la producción de catecolaminas y pueden ser funcionales o no funcionantes; tienen un componente hereditario importante, y son considerados la neoplasia con mayor carga genética que requieren una evaluación preoperatoria adecuada, con el fin de prevenir y disminuir las complicaciones graves de la hipersecreción de catecolaminas. El manejo preoperatorio contribuye a disminuir las tasas de morbimortalidad en los pacientes que no han sido diagnosticados con esta entidad y son sometidos a cualquier cirugía. Sin embargo, la mortalidad actual parece ser más baja, hecho atribuido a un manejo preoperatorio con ?-bloqueadores.

Biografía del autor/a

Jean Andrés Peralta Maldonado, Investigador Independiente

Magíster en Seguridad y Salud Ocupacional, Médico, Investigador Independiente, Guayaquil, Ecuador

Marcia Dayanna Higuera Martos, Investigador Independiente

Médica, Investigador Independiente, Guayaquil, Ecuador

Ayrianna Katiusca Galán Velasco, Investigador Independiente

Médica, Investigador Independiente, Guayaquil, Ecuador

Karla Estefanía Baquerizo Rosales, Investigador Independiente

Magíster en Gestión Hospitalaria y Nuevas Tecnologías, Médico, Investigador Independiente, Guayaquil, Ecuador

Citas

Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: acomprehensive review. J Clin Endocrinol Metab. 2009;94:1853–78.

Lenders JW, Eisenhofer G, Mannelli M PK, Lenders JWM, Eisenhofer G, Mannelli M,Pacak K. Phaeochromocytoma. Lancet. 2005;366:665–75.

van der Horst-Schrivers AN, Kerstens MN, Wolffenbuttel BH. Preoperativepharmacological management of phaeochromocytoma. Neth J Med. 2006;64:290–5.

Kopetschke R, Slisko M, Kilisli A, Tuschy U, Wallaschofski H, Fassnacht M, et al. Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol. 2009;161:355–61.

Mannelli M, Ianni L, Cilotti A, Conti A. Pheochromocytoma in Italy: A multicentric retrospective study. Eur J Endocrinol. 1999;141:619–24.

Opotowsky AR, Moko LE, Ginns J, Rosenbaum, M. Greutmann M, Aboulhosn J, Hageman A, et al. Pheochromocytoma and Paraganglioma in Cyanotic Congenital HeartDisease. J Clin Endocrinol Metab. 2015;100:1325–34.

Martucci VL, Pacak K. Pheochromocytoma and Paraganglioma: Diagnosis, Genetics, Management, and Treatment. Curr Probl Cancer. 2014;38:7–41.

Kinney MA, Warner ME, vanHeerden JA, Horlocker TT, Young WF, Schroeder DR, et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg. 2000;91:1118–23.

Soltani A, Pourian M, Mostafazadeh DB. Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms. J Diabetes Metab Disord. 2016;15:1–12.

Guerrero MA, Schreinemakers JMJ, Vriens MR, Suh I, Hwang J, Shen WT, et al. Clinical Spectrum of Pheochromocytoma. J Am Coll Surg. 2009;209:727–32.

Ahmed I. Recognition and management of phaeochromocytoma. Anaesth Intensive Care Med. 2014;15:465–9.

McNeil AR, Blok BH, Koelmeyer TD, Burke MP, Hilton JM. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust N Z J Med. 2000;30:648–52.

Lo CY, Lam KY, Wat MS, Lam KS. Adrenal pheochromocytoma remains a frequently overlooked diagnosis. Am J Surg. 2000;179:212–5.

Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab. 2005;90:2110–6.

Kramer CK, Leitão CB, Azevedo MJ, Canani LH, Maia AL, Czepielewski M, et al. Degree of catecholamine hypersecretion is the most important determinant of intra-operative hemodynamic outcomes in pheochromocytoma. J Endocrinol Invest. 2009;32:234–7. VII. Bibliografía 174

Motta-Ramirez GA, Remer EM, Herts BR, Gill IS, Hamrahian AH. Comparison of CT Findings in Discovered Pheochromocytomas. Am J Roentgenol. 2005;185:684–8.

Noshiro T, Shimizu K, Watanabe T, Akama H, Shibukawa S, Miura W, et al. Changes in clinical features and long-term prognosis in patients with pheochromocytoma. Am JHypertens. 2000;13:35–43.

Shen WT, Grogan R, Vriens M, Clark OH, Duh Q-Y. One hundred two patients with pheochromocytoma treated at a single institution since the introduction of laparoscopic adrenalectomy. Arch Surg. 2010;145:893–7.

Lafont M, Fagour C, Haissaguerre M, Darancette G, Wagner T, Corcuff JB, et al. Peroperative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas. J Clin Endocrinol Metab. 2015;100:417–21.

Cheah WK, Clark OH, Horn JK, Siperstein AE, Duh QY. Laparoscopic adrenalectomy for pheochromocytoma. World J Surg. 2002;26:1048–51.

Gaujoux S, Bonnet S, Lentschener C, Thillois JM, Duboc D, Bertherat J, et al. Preoperative risk factors of hemodynamic instability during laparoscopic adrenalectomy for pheochromocytoma. Surg Endosc. 2016;30:2984–93.

Haissaguerre M, Courel M, Caron P, Denost S, Dubessy C, Gosse P, et al. Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular , and molecular characteristics. J Clin Endocrinol Metab. 2013;98:4346–54.

Goldstein RE, O’Neill J a, Holcomb GW, Morgan WM, Neblett WW, Oates J a, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg. 1999;229:755– 66.

Gagner M, Lacroix A, Bolté E. Laparoscopic adrenalectomy in Cushing´s syndrome and pheochromocytoma. N Engl J Med. 1992;327:1033.

Joris JL, Hamoir EE, Hartstein GM, Meurisse MR, Hubert BM, Charlier CJ, et al. Hemodynamic changes and catecholamine release during laparoscopic adrenalectomy for pheochromocytoma. Anesth Analg. 1999;88:16–21.

Namekawa T, Utsumi T, Kawamura K. Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2016;159:763–70.

Brunaud L, Boutami M, Nguyen-Thi P-L, Finnerty B, Germain A, Weryha G, et al. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery. 2014;156:1410–8.

Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: Analysis of 165 operations at a single center. J Clin Endocrinol Metab. 2001;86:1480–6.

Kazaryan AM, Kuznetsov NS, Shulutko AM, Beltsevich DG, Edwin B. Evaluation of endoscopic and traditional open approaches to pheochromocytoma. Surg Endosc. 2004;18:937–41. VII. Bibliografía 175

Joris JL, Noirot DP, Legrand MJ, Jacquet NJ, Lamy ML. Hemodynamic Changes During Laparoscopic Cholecystectomy. Anesth Analg. 1993;76:1067–71.

Sprung J, O’Hara JF, Gill IS, Abdelmalak B, Sarnaik A, Bravo EL. Anesthetic aspects of laparoscopic and open adrenalectomy for pheochromocytoma. Urology. 2000;55:339– 43.

Meurisse M, Joris J, Hamoir E, Hubert B, Charlier C. Laparoscopic removal of pheochromocytoma Why? When? and Who? (Reflections on one case report). Surg Endosc. 1995;9:431–6.

Rocha MF, Tauzin-Fin P, Vasconcelos PL, Ballanger P. Assesssment of serum catecholamine concentrations in patients with pheochromocytoma undergoing videolaparoscopic adrenalectomy. Int Braz J Urol. 2005;31:299–307.

de La Chapelle A, Deghmani M, Dureuil B. Peritoneal insufflation can be a critical moment in the laparoscopic surgery of pheochromocytoma. Ann Fr Anesth Reanim. 1998;17:1184–5.

Tauzin-Fin P, Sesay M, Gosse P, Ballanger P. Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. Br J Anaesth. 2004;92:512–7.

Fernández-Cruz L, Taurá P, Sáenz A, Benarroch G, Sabater L. Laparoscopic Approach to Pheochromocytoma?: Hemodynamic Changes and Catecholamine Secretion. World J Surg. 1996;20:762–8.

Rose CE, Althaus JA, Kaiser DL, Miller ED, Carey RM. Acute hypoxemia and hypercapnia: increase in plasma catecholamines in conscious dogs. Am J Physiol. 1983;245:924–9.

Fitzgerald SD, Andrus CH, Baudendistel LJ, Dahms TE, Kaminski DL. Hypercarbia during carbon dioxide pneumoperitoneum. Am J Surg. 1992;163:186–90.

Leighton TA, Liu SY, Bongard FS. Comparative cardiopulmonary effects of carbon dioxide versus helium pneumoperitoneum. Surgery. 1993;113:527–31.

McMahon AJ, Baxter JN, Murray W, Imrie CW, Kenny G, O’Dwyer PJ. Helium pneumoperitoneum for laparoscopic cholecystectomy: Ventilatory and blood gas changes. Br J Surg. 1994;81:1033–6.

Fernandez-Cruz L, Saenz A, Taura P, Benarroch G, Nies C, Astudillo E. Pheochromocytoma: laparoscopic approach with CO2 and helium pneumoperitoneum. Endosc Surg Allied Technol. 1994;2:300–4.

Cheng Y, Lu J, Xiong X, Wu S, Lin Y, Wu T, et al. Gases for establishing pneumoperitoneum during laparoscopic abdominal surgery. Cochrane Database Syst Rev. 2013;1:CD009569.

Gumbs AA, Gagner M. Laparoscopic adrenalectomy. Best Pract Res Clin Endocrinol Metab. 2006;20:483–99.

Walz MK, Alesina PF, Wenger FA, Koch JA, Neumann HPH, Petersenn S, et al. Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: Results of 161 tumors in 126 patients. World J Surg. 2006;30:899–908.

Descargas

Publicado

2023-12-22

Cómo citar

Jean Andrés Peralta Maldonado, Marcia Dayanna Higuera Martos, Ayrianna Katiusca Galán Velasco, & Karla Estefanía Baquerizo Rosales. (2023). Factores de riesgo de descarga catecolaminérgica y/o inestabilidad hemodinámica en la cirugía del feocromocitoma. Dominio De Las Ciencias, 9(4), 1814–1832. https://doi.org/10.23857/dc.v9i4.3699

Número

Sección

Artí­culos Cientí­ficos